CompletedPhase 4ACTRN12611000555954
Efficacy of Silodosin in Expulsive Therapy of Lower Ureteral Stones: A Randomized Controlled trial
Efficacy of silodosin in expulsive therapy of lower ureteral stones
Sponsor
Chung Jing Wang
Enrollment
55 participants
Start Date
May 1, 2010
Study Type
Interventional
Conditions
Summary
perform a comparative study to evaluate the clinical role of silodosin in the medical expulsive therapy of symptomatic lower ureteral stones.
Eligibility
Sex: Both males and femalesMin Age: 20 YearssMax Age: 60 Yearss
Inclusion Criteria1
- patients with radiopaque lower ureteral stones>5mm
Exclusion Criteria1
- urinary tract infections, high-grade hydronephrosis, diabetes, ulcers, or a history of hypersensitivity toa-1 blocker and pregnant women were excluded. Patients with a history of spontaneous stone expulsion, hypotension, or those found to have systolic blood pressure lower than 110 mmHg
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
silodosin (4 mg daily) orally for 2 weeks
silodosin (4 mg daily) orally for 2 weeks
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12611000555954